Why the study?
Malignant hypertension is an extremely severe form of hypertension with target organ impairment, and resveratrol has been proposed as an effective agent in preventing cardiovascular diseases.
Does chronic resveratrol administration reduce blood pressure and improve cardiac structure in spontaneously and malignantly hypertensive rats?
Does chronic resveratrol administration reduce blood pressure and improve cardiac structure in spontaneously and malignantly hypertensive rats?
In a rat model, resveratrol prevents hypertrophic and apoptotic consequences of high blood pressure, with pronounced protective effects in malignant hypertension.
Answers are grounded in this paper and cite their sources.
Resveratrol's benefits in hypertensive rats should not change clinical practice; hypothesis-generating for human trials.
Hypertension is one of the most prevalent and powerful contributors of cardiovascular diseases. Malignant hypertension is a relatively rare but extremely severe form of hypertension accompanied with heart, brain, and renal impairment. Resveratrol, a recently described grape-derived, polyphenolic antioxidant molecule, has been proposed as an effective agent in the prevention of cardiovascular diseases. This study was designed to examine chronic resveratrol administration on blood pressure, oxidative stress, and inflammation, with special emphasis on cardiac structure and function in two models of experimental hypertension. The experiments were performed in spontaneously (SHRs) and malignantly hypertensive rats (MHRs). The chronic administration of resveratrol significantly decreased blood pressure in both spontaneously and malignant hypertensive animals. The resveratrol treatment ameliorated morphological changes in the heart tissue. The immunohistochemistry of the heart tissue after resveratrol treatment showed that both TGF-β and Bax were not present in the myocytes of SHRs and were present mainly in the myocytes of MHRs. Resveratrol suppressed lipid peroxidation and significantly improved oxidative status and release of NO. These results suggest that resveratrol prevents hypertrophic and apoptotic consequences induced by high blood pressure with more pronounced effects in malignant hypertension.
No takes yet. Share an insight, caveat, or question.
Grujić-Milanović et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: